309 related articles for article (PubMed ID: 25882762)
1. Effect of menopause hormone therapy on disease progression in systemic lupus erythematosus: A systematic review.
Khafagy AM; Stewart KI; Christianson MS; Tao Y; Blanck JF; Shen W
Maturitas; 2015 Jun; 81(2):276-81. PubMed ID: 25882762
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review.
Soares-Jr JM; Espósito Sorpreso IC; Nunes Curado JF; Ferreira Filho ES; Dos Santos Simões R; Bonfá E; Silva CA; Baracat EC
Climacteric; 2022 Oct; 25(5):427-433. PubMed ID: 35438053
[TBL] [Abstract][Full Text] [Related]
3. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
4. Menopause hormonal therapy in women with systemic lupus erythematosus.
Sánchez-Guerrero J; González-Pérez M; Durand-Carbajal M; Lara-Reyes P; Jiménez-Santana L; Romero-Díaz J; Cravioto MD
Arthritis Rheum; 2007 Sep; 56(9):3070-9. PubMed ID: 17763408
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus and menopause.
Gompel A
Climacteric; 2020 Apr; 23(2):109-115. PubMed ID: 31657240
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
Sánchez-Guerrero J; Liang MH; Karlson EW; Hunter DJ; Colditz GA
Ann Intern Med; 1995 Mar; 122(6):430-3. PubMed ID: 7856991
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD
Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
[TBL] [Abstract][Full Text] [Related]
8. Do flares of systemic lupus erythematosus decline after menopause?
Mok CC; Lau CS; Ho CT; Wong RW
Scand J Rheumatol; 1999; 28(6):357-62. PubMed ID: 10665741
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
[TBL] [Abstract][Full Text] [Related]
10. Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review.
Rodríguez Huerta MD; Trujillo-Martín MM; Rúa-Figueroa Í; Cuellar-Pompa L; Quirós-López R; Serrano-Aguilar P;
Semin Arthritis Rheum; 2016 Feb; 45(4):463-70. PubMed ID: 26522137
[TBL] [Abstract][Full Text] [Related]
11. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus.
Sánchez-Guerrero J; Villegas A; Mendoza-Fuentes A; Romero-Díaz J; Moreno-Coutiño G; Cravioto MC
Am J Med; 2001 Oct; 111(6):464-8. PubMed ID: 11690572
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus.
Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
Cochrane Database Syst Rev; 2000; (3):CD002265. PubMed ID: 10908541
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in systemic lupus erythematosus.
Kreidstein S; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1997 Nov; 24(11):2149-52. PubMed ID: 9375875
[TBL] [Abstract][Full Text] [Related]
14. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
Mok CC; Ying SK; Ma KM; Wong CK
Lupus; 2013 Dec; 22(14):1470-8. PubMed ID: 24113197
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
Cochrane Database Syst Rev; 2006 Apr; (2):CD002265. PubMed ID: 16625558
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis.
Cintron D; Lipford M; Larrea-Mantilla L; Spencer-Bonilla G; Lloyd R; Gionfriddo MR; Gunjal S; Farrell AM; Miller VM; Murad MH
Endocrine; 2017 Mar; 55(3):702-711. PubMed ID: 27515805
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
Ruiz-Irastorza G; Ramos-Casals M; Brito-Zeron P; Khamashta MA
Ann Rheum Dis; 2010 Jan; 69(1):20-8. PubMed ID: 19103632
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus.
Cintrón D; Alanis JM; Álvarez-Villalobos N; Rodríguez-Gutiérrez R; Vilá LM
Lupus; 2020 Mar; 29(3):303-310. PubMed ID: 32031032
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of prevalence, disease characteristics and management of systemic lupus erythematosus in Australia: identifying areas of unmet need.
Nikpour M; Bridge JA; Richter S
Intern Med J; 2014 Dec; 44(12a):1170-9. PubMed ID: 25169712
[TBL] [Abstract][Full Text] [Related]
20. Impact of menopause on women with systemic lupus erythematosus.
Karvonen-Gutierrez CA; Leis A
Maturitas; 2021 Dec; 154():25-30. PubMed ID: 34736577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
